Comparison of main trials of recombinant human activated protein C in sepsis-are we encouraging more bleeding in neonates?
Huei
H
Hsin Shieh
Eliane
E
Roseli Barreira
Patricia
P
Freitas Góes
Albert
A
Bousso
Gabriel Alberto
GA
Ventura Brazilian
Ana Maria
AM
Melo
Silvia Maria
SM
Ibidi
D000990:Antithrombin III / Q000032:analysis / Q000378:metabolism*; D001777:Blood Coagulation / Q000502:physiology; D002986:Clinical Trials as Topic; D020345:Enterocolitis, Necrotizing / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D006801:Humans; D007231:Infant, Newborn; D020300:Intracranial Hemorrhages / Q000453:epidemiology / Q000209:etiology / Q000517:prevention & control; D011486:Protein C / Q000032:analysis / Q000378:metabolism*; D017293:Protein S / Q000032:analysis / Q000378:metabolism; D018570:Risk Assessment; D018805:Sepsis / Q000150:complications / Q000503:physiopathology*; D012720:Severity of Illness Index; D013923:Thromboembolism / Q000517:prevention & control
D011486:Protein C; D017293:Protein S; D000990:Antithrombin III